公开(公告)号：US20240258060A1

公开(公告)日：2024-08-01

申请号：US18636379

申请日：2024-04-16

Applicant: Genenxa Inc.

Inventor： Max Spielberg ,  David Johnson

IPC: H01J9/18 ,  B23K1/00 ,  B23K3/08 ,  B23K101/36 ,  H01J35/08

CPC classification number: H01J9/18 ,  B23K1/0016 ,  B23K3/087 ,  H01J35/08 ,  B23K2101/36 ,  H01J2235/084

Abstract: The present invention relates to an aqueous pharmaceutical suspension composition having from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and microcrystalline cellulose; an effective amount of taste masking compositions; and water, as well as a process for producing such aqueous pharmaceutical suspensions.

公开(公告)号：US20240226040A1

公开(公告)日：2024-07-11

申请号：US18619076

申请日：2024-03-27

Applicant: Genenxa Inc.

Inventor： Max Spielberg ,  David Johnson

IPC: A61K31/167 ,  A61K9/20

CPC classification number: A61K31/167 ,  A61K9/2013 ,  A61K9/2068

Abstract: A tablet includes an active material and a base material comprising carnauba wax and an oil. A tablet formulation can contain an active pharmaceutical ingredient and a base material that includes carnauba wax. The carnauba wax constitutes more than 50% of the base material.